About this episode

The episode discusses the challenges in drug development and the role of AI in overcoming coordination issues in clinical trials with guest Anastasia Christianson.

Send us Fan Mail AI is everywhere in pharma right now, yet drug development still feels slow, fragmented, and full of avoidable rework. We sit down with Anastasia Christianson, former SVP and Global Head of AI Data and Analytics at Pfizer and now Managing Principal at EPAM Life Science Consulting, to get specific about what actually blocks progress in clinical trials and what AI can realistically change. We dig into the uncomfortable pattern behind many “successful” AI deployments: a model f...

People in this episode

Host: Ivanna Rosendal

Guest: Anastasia Christianson

Topics covered

• AI in pharma
• clinical trials
• drug development
• data analytics
• coordination challenges

Keywords

• AI
• pharma
• clinical trials
• drug development
• data analytics
• coordination

Mentioned in this episode

Organizations: Pfizer, EPAM Life Science Consulting

Explore listener stats, chart rankings, contacts and more on the Lab to Lives podcast page.